Joanne Van Zuidam
Editor

Joanne Van Zuidam is the editor of Drug Discovery & Development. An experienced health editor, she previously served as editor of Optometric Office magazine, a publication highlighting new products and technology for eye care professionals. As a freelance writer, she has written extensively on a broad range of health and wellness topics for numerous national magazines and websites. 

A new study found patients with severe asthma treated with benralizumab, a potential new medicine, were more than four times likely to reduce their usage of...
5.26.2017
11:16am
The Member States of World Health Organization (WHO) elected Tedros Adhanom Ghebreyesus, Ph.D., of Ethiopia as the new Director-General of WHO.
5.24.2017
11:27am
This is the sixth FDA approval for Actemra since it was launched in 2010—and the first drug approved to specifically treat patients with Giant Cell Arteritis.
5.23.2017
11:58am
Among patients with persistent hypercapnia (excess carbon dioxide in their blood) following a COPD exacerbation, the addition of a home ventilator device to...
5.22.2017
12:08pm
The disease is endemic in approximately 60 countries and causes epidemics as well. It is estimated that cholera results in 2.9 million cases of disease and 95,...
5.19.2017
11:59am
Advertisement
Based on two clinical trials, the FDA has concluded that the type 2 diabetes drug canagliflozin, manufactured by Johnson & Johnson, causes an increased...
5.18.2017
12:51pm
Researchers in an international clinical trial tested whether the blood clot stabilizer could become an essential tool for fighting excessive bleeding soon...
5.16.2017
12:02pm
Researchers from the Intermountain Medical Center Transplant Program found that liver transplant patients taking everolimus (Afinitor) gained less weight – and...
5.15.2017
12:34pm
FDA actions included three drug withdrawals, 61 boxed warnings and 59 safety communications, according to a Yale-led study.
5.10.2017
8:55am
Aspergillus niger-derived prolyl endoprotease (AN-PEP), was found to break down small amounts of gluten within the digestive system.
5.8.2017
11:53am
Quest Diagnostics has agreed to pay $6 million to resolve a lawsuit brought by the United States government that alleged that Berkeley Heartlab—a Quest...
5.5.2017
10:32am
The U.S. Food and Drug Administration (FDA) has issued 14 warning letters and four online advisory letters addressed to U.S.-based companies illegally selling...
5.4.2017
9:51am